The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice

The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice Rationale Alcohol use disorders have become one of the most ethanol intake and preference in C57BL/6J mice treated with damaging psychiatric disorders in the world; however, there roflumilast (1, 3, or 10 mg/kg) or rolipram (0.5 mg/kg; posi- are no ideal treatments in clinic. Phosphodiesterase-4 (PDE4), tive control). The effect of roflumilast was verified using the an enzyme that specifically hydrolyzes intracellular cyclic ethanol drinking-in-dark (DID) test. Locomotor activity was AMP (cAMP), has been involved in alcohol use disorders. examined using the open-field test. Intake of sucrose or qui- Roflumilast is the first PDE4 inhibitor approved for treatment nine was also tested to determine whether natural reward pref- of chronic obstructive pulmonary diseases in clinic. It was of erence and aversive stimuli were involved in the effect of particular interest to researchers to determine whether PDE4 inhibitors. roflumilast altered ethanol consumption. Results Similar to rolipram, roflumilast decreased ethanol in- Objectives The present study tried to determine the effects of take and preference in two-bottle choice and DID tests in a roflumilast on ethanol intake and preference. dose-dependent manner, with significant changes at the dose of 10 mg/kg; in contrast, roflumilast did not affect sucrose or quinine drinking, although it http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychopharmacology Springer Journals

The phosphodiesterase-4 inhibitor roflumilast decreases ethanol consumption in C57BL/6J mice

Loading next page...
 
/lp/springer_journal/the-phosphodiesterase-4-inhibitor-roflumilast-decreases-ethanol-SCdaD0Qa0f
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Biomedicine; Neurosciences; Pharmacology/Toxicology; Psychiatry
ISSN
0033-3158
eISSN
1432-2072
D.O.I.
10.1007/s00213-017-4631-8
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial